Ventracor raises $33m in rights issue
Wednesday, 29 October, 2003
Ventracor (ASX:VCR) has closed its renounceable rights issue, raising approximately AUD$33 million in an offer oversubscribed by $12 million.
Chairman John Massey said the allocation of shares applied for under the top-up facility would be preferentially distributed to small shareholders. Trading of the new shares is expected to begin this Friday, 31 October.
The offer increases Ventracor's cash reserves to around $74 million. Massey said the funds would be used to finance the company's clinical trials for its VentrAssist device, and also to look at alternative uses for the device.
"The funding allows us to move forward as quickly as possible without being impeded by a lack of funds," he said.
Relapse risk predicted for little-known autoimmune disease
Often referred to as a cousin of MS due to shared symptoms, MOGAD is a little-known autoimmune...
Perinatal HIV transmission may lead to cognitive deficits
Perinatal transmission of HIV to newborns is associated with serious cognitive deficits as...
Gene editing could make quolls resistant to cane toad toxin
Scientists from Colossal Biosciences and The University of Melbourne have introduced genetic...
